19 November 2017
News and Views
Links and Services
January's issue of the Alimentary Pharmacology & Therapeutics reviews the influence of pioglitazone on liver histology and fibrosis in patients with non-alcoholic steatohepatitis.
Thiazolidinediones have been used in the treatment of non-alcoholic steatohepatitis (NASH).
Email this page to a colleague
GastroHep.com is a Blackwell Publishing registered trademark
© 2017 Wiley-Blackwell and GastroHep.com and contributors